Sunwin Stevia International Inc. (OTCQB: SUWN) one of the top global providers of high quality stevia extracts including Rebaudioside A 98 and Rebaudioside A 99, announced that it has submitted a patent application for its enzyme-treated stevia products.
For years stevia usage has not been widely accepted as a natural sweetener, because it has a bitter, licorice-like aftertaste even with high-grade stevia such as Rebaudioside A 98 and Rebaudioside A 99. To resolve the issue, Sunwin Stevia has been working with scientists to develop enzyme-treated stevia for years. The enzyme-treated stevia product is obtained by addition of glucose to stevia extracts using α-glucosyltransferase. In addition, a special treat stevia seed is required to grow special stevia leaf for such advanced product. This new method can effectively decrease or eliminate the bitter aftertaste of natural stevia. Sunwin Stevia is the only company in the world that offers such advanced products on a commercial basis.
"We launched the revolutionary products in 2013 and they have been receiving wide acceptance in the U.S. by our customers. The new patent will protect our intellectual rights for our advanced enzyme-treated stevia products. Management expects the demand for our enzyme-treated stevia products will be increased substantially in the years to come," commented Ms. Dongdong Lin, CEO of Sunwin Stevia. "We believe our enzyme-treated stevia products will be a mainstay in the industry and will dominate the global stevia markets for years to come."